Newport Pharmaceuticals

Click on links below to download files in MS Word format.
	Designing therapeutic studies in Chronic Fatigue Syndrome (CFS) - Dilemmas from the investigator's and the industry's perspectives. September 2004
	Clinical improvement in chronic fatigue syndrome is associated with enhanced natural killer cell-mediated cytotoxicity: the results of a pilot study with Isoprinosine® Journal of Chronic Fatigue Syndrome, 2003.
	Randomized Treatment Study of Inosiplex Versus Combined Inosiplex and Intraventricular Interferon- in Subacute Sclerosing Panencephalitis (SSPE): International Multicenter Study December, 2003
	Randomized treatment study of inosiplex versus combined inosiplex and intraventricular alpha interferon in subacute sclerosing panencephalitis (SSPE) September 2003
	Inosine Pranobex in the treatment of chronic fatigue syndrome - a pilot study May 2002
	Clinical Improvement In Chronic Fatigue Syndrome Is Associated With Enhanced Natural Killer Cell Mediated Cytotoxicity: The Results Of A Pilot Study With Isoprinosine® May 2000